Trials / Completed
CompletedNCT00035854
New Antibiotic to Treat Pediatric Patients With Infections Due to a Specific Bacteria (Vancomycin-Resistant Enterococcus)
Linezolid IV/PO for the Treatment of Vancomycin-Resistant Enterococcus Infections in Children
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 13 (actual)
- Sponsor
- Pfizer · Industry
- Sex
- All
- Age
- 17 Years
- Healthy volunteers
- Not accepted
Summary
This study will treat pediatric patients who have infections that are due to a specific bacteria (Vancomycin-Resistant Enterococcus)
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Zyvox® / Linezolid |
Timeline
- Start date
- 2002-02-01
- Completion
- 2004-05-01
- First posted
- 2002-05-07
- Last updated
- 2009-08-14
Locations
21 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00035854. Inclusion in this directory is not an endorsement.